<DOC>
	<DOCNO>NCT03034408</DOCNO>
	<brief_summary>Impulsivity central feature addiction . Nalmefen authorize treatment alcohol addiction . Baclofen empathically advocate efficacy indication . The aim present study test effect Nalmefene Baclofen impulsivity . Primary study objective : To examine effect Nalmefene Baclofen impulsivity ( measure Stop Signal Task ) subject alcohol use disorder healthy control subject . Main secondary study objective : To examine effect Nalmefene Baclofen risk take ( measure Balloon Analogue Risk Task ) preference small immediate reward large delay reward ( measure Delay Discounting Task ) . To compare subject alcohol use disorder healthy control subject task . Primary study outcome : Stop-signal reaction time Stop-Signal Task Main secondary study outcome : Equivalence point Delay-Discounting Task Average number pump deliver Balloon Analogue Risk Task Study Design : Randomized , placebo control , cross-over , single-dose</brief_summary>
	<brief_title>Nalmefene , Baclofen Impulsivity Subjects With Alcohol Use Disorder Healthy Control Subjects</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Impulsive Behavior</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Nalmefene</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>30 patient DSM5 Diagnosis Alcohol Use Disorder , least moderate ( 303.90/F10.20 ) , 30 sex agematched healthy control , 18 , inform consent . opiatetreatment , contraindication Nalmefene and/or Baclofen , unstable psychiatric disorder , pregnancy , acute withdrawal syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Impulsivity</keyword>
	<keyword>Nalmefene</keyword>
	<keyword>Baclofen</keyword>
</DOC>